Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review

Reports of pulmonary aspergillosis and mucormycosis co-infections are rare; thus, limited guidance is available on early diagnosis and treatment. We present a case of mixed pulmonary Aspergillus and Mucor infection and review the literature regarding this co-infection. The diagnosis and treatment me...

Full description

Saved in:
Bibliographic Details
Published in:BMC pulmonary medicine 2024-09, Vol.24 (1), p.436-6, Article 436
Main Authors: Ling, Fei-Xiang, Qu, Dong-Ming, Lu, Ye-Quan, Li, Rou, Zhao, Lei
Format: Article
Language:English
Subjects:
Amphotericin B
Amphotericin B - administration & dosage
Amphotericin B - therapeutic use
Antifungal agents
Antifungal Agents - administration & dosage
Antifungal Agents - therapeutic use
Antiparasitic agents
Aspergillosis
Aspergillus
Biopsy
Blood vessels
Bronchoscopic treatment
Bronchoscopy
Care and treatment
Case Report
Case reports
Coinfection - drug therapy
Complications and side effects
Coronaviruses
COVID-19
Development and progression
Diabetes
Diabetes mellitus
Diagnosis
Disease
Dosage and administration
Drug therapy
Drugs
Fatalities
Fungal infections
Health aspects
Hospitals
Humans
Immunosuppressive agents
Infection
Invasive fungal infections
Literature reviews
Lung diseases
Lung diseases, Fungal
Lungs
Male
Medical prognosis
Middle Aged
Mortality
Mucor
Mucor - isolation & purification
Mucormycosis
Mucormycosis - diagnosis
Mucormycosis - drug therapy
Pathogens
Patient outcomes
Patients
Pneumonia
Posaconazole
Pulmonary aspergillosis
Pulmonary Aspergillosis - diagnosis
Pulmonary Aspergillosis - drug therapy
Pulmonary mucormycosis
Sulbactam
Surgery
Tomography, X-Ray Computed
Tuberculosis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c445t-ec4397a10a92351c9c9ee535f9fb3e30772558889d294c49551ea5258d5f36053
container_end_page 6
container_issue 1
container_start_page 436
container_title BMC pulmonary medicine
container_volume 24
creator Ling, Fei-Xiang
Qu, Dong-Ming
Lu, Ye-Quan
Li, Rou
Zhao, Lei
description Reports of pulmonary aspergillosis and mucormycosis co-infections are rare; thus, limited guidance is available on early diagnosis and treatment. We present a case of mixed pulmonary Aspergillus and Mucor infection and review the literature regarding this co-infection. The diagnosis and treatment methods are summarized to improve clinicians' understanding of the disease and to facilitate early diagnosis and treatment. A 60-year-old male farmer with poorly controlled diabetes mellitus was admitted to hospital with a fever of unknown origin that had been present for 15 days and pulmonary aspergillosis complicated by Mucor spp. Because multiple lobes were involved, the infection worsened despite surgical resection and antifungal therapy. Finally, we treated this patient with a bronchoscopic infusion of amphotericin B. After four courses of bronchoscopic amphotericin B infusion, we observed rapid clinical improvement and subsequent resolution of pulmonary infiltrates. Our case highlights the use of bronchoscopy in the successful clinical treatment of invasive fungal diseases of the lung.
doi_str_mv 10.1186/s12890-024-03234-z
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_f08a1abe94744db19391e871dcae7562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A808321940</galeid><doaj_id>oai_doaj_org_article_f08a1abe94744db19391e871dcae7562</doaj_id><sourcerecordid>A808321940</sourcerecordid><originalsourceid>FETCH-LOGICAL-c445t-ec4397a10a92351c9c9ee535f9fb3e30772558889d294c49551ea5258d5f36053</originalsourceid><addsrcrecordid>eNptkstu1DAUhiMEoqXwAiyQJTZsUnyNbTZoqLhUKmIBrC2PczLjUWIHOynQN-FtcWZKaRHywvbx9__2OT5V9ZTgU0JU8zITqjSuMeU1ZpTx-upedUy4JDXlTXP_1vqoepTzDmMilWAPqyOmKaOSyOPq1-fZOci5m3s0JbDTAGFCsUOD_wEtGud-iMGmn2iVR0gb3_dzRja06OPsYkI-dOAmHwOasw-bsp-SXacY3NbbHtlh3MYJknc-oDcLXbAYXiGLnM2AEowxTXu_3hfOTnNaopcevj-uHnS2z_Dkej6pvr57--XsQ33x6f352eqidpyLqQbHmZaWYFtyEsRppwEEE53u1gwYlpIKoZTSLdXccS0EASuoUK3oWIMFO6nOD75ttDszJj-UdE203uwDMW2MTZN3PZgOK0vsGjSXnLdropkmoCRpnQUpGlq8Xh-8xnk9QOtgKUd_x_TuSfBbs4mXhhAmGcG6OLy4dkjx2wx5MoPPDvreBohzNgXCmjSUyII-_wfdxTmFUquForx8tSB_qY0tGZQfiOVit5ialcKKUaI5LtTpf6gyWhi8iwE6X-J3BPQgcCnmnKC7SZJgs3SnOXSnKQ8x--40V0X07HZ5biR_2pH9BuOb4bc</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3102485351</pqid></control><display><type>article</type><title>Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><source>Coronavirus Research Database</source><creator>Ling, Fei-Xiang ; Qu, Dong-Ming ; Lu, Ye-Quan ; Li, Rou ; Zhao, Lei</creator><creatorcontrib>Ling, Fei-Xiang ; Qu, Dong-Ming ; Lu, Ye-Quan ; Li, Rou ; Zhao, Lei</creatorcontrib><description>Reports of pulmonary aspergillosis and mucormycosis co-infections are rare; thus, limited guidance is available on early diagnosis and treatment. We present a case of mixed pulmonary Aspergillus and Mucor infection and review the literature regarding this co-infection. The diagnosis and treatment methods are summarized to improve clinicians' understanding of the disease and to facilitate early diagnosis and treatment. A 60-year-old male farmer with poorly controlled diabetes mellitus was admitted to hospital with a fever of unknown origin that had been present for 15 days and pulmonary aspergillosis complicated by Mucor spp. Because multiple lobes were involved, the infection worsened despite surgical resection and antifungal therapy. Finally, we treated this patient with a bronchoscopic infusion of amphotericin B. After four courses of bronchoscopic amphotericin B infusion, we observed rapid clinical improvement and subsequent resolution of pulmonary infiltrates. Our case highlights the use of bronchoscopy in the successful clinical treatment of invasive fungal diseases of the lung.</description><identifier>ISSN: 1471-2466</identifier><identifier>EISSN: 1471-2466</identifier><identifier>DOI: 10.1186/s12890-024-03234-z</identifier><identifier>PMID: 39232717</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Amphotericin B ; Amphotericin B - administration &amp; dosage ; Amphotericin B - therapeutic use ; Antifungal agents ; Antifungal Agents - administration &amp; dosage ; Antifungal Agents - therapeutic use ; Antiparasitic agents ; Aspergillosis ; Aspergillus ; Biopsy ; Blood vessels ; Bronchoscopic treatment ; Bronchoscopy ; Care and treatment ; Case Report ; Case reports ; Coinfection - drug therapy ; Complications and side effects ; Coronaviruses ; COVID-19 ; Development and progression ; Diabetes ; Diabetes mellitus ; Diagnosis ; Disease ; Dosage and administration ; Drug therapy ; Drugs ; Fatalities ; Fungal infections ; Health aspects ; Hospitals ; Humans ; Immunosuppressive agents ; Infection ; Invasive fungal infections ; Literature reviews ; Lung diseases ; Lung diseases, Fungal ; Lungs ; Male ; Medical prognosis ; Middle Aged ; Mortality ; Mucor ; Mucor - isolation &amp; purification ; Mucormycosis ; Mucormycosis - diagnosis ; Mucormycosis - drug therapy ; Pathogens ; Patient outcomes ; Patients ; Pneumonia ; Posaconazole ; Pulmonary aspergillosis ; Pulmonary Aspergillosis - diagnosis ; Pulmonary Aspergillosis - drug therapy ; Pulmonary mucormycosis ; Sulbactam ; Surgery ; Tomography, X-Ray Computed ; Tuberculosis</subject><ispartof>BMC pulmonary medicine, 2024-09, Vol.24 (1), p.436-6, Article 436</ispartof><rights>2024. The Author(s).</rights><rights>COPYRIGHT 2024 BioMed Central Ltd.</rights><rights>2024. This work is licensed under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>The Author(s) 2024 2024</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c445t-ec4397a10a92351c9c9ee535f9fb3e30772558889d294c49551ea5258d5f36053</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC11373109/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/3102485351?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,25732,27903,27904,36991,36992,38495,43874,44569,53769,53771</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39232717$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ling, Fei-Xiang</creatorcontrib><creatorcontrib>Qu, Dong-Ming</creatorcontrib><creatorcontrib>Lu, Ye-Quan</creatorcontrib><creatorcontrib>Li, Rou</creatorcontrib><creatorcontrib>Zhao, Lei</creatorcontrib><title>Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review</title><title>BMC pulmonary medicine</title><addtitle>BMC Pulm Med</addtitle><description>Reports of pulmonary aspergillosis and mucormycosis co-infections are rare; thus, limited guidance is available on early diagnosis and treatment. We present a case of mixed pulmonary Aspergillus and Mucor infection and review the literature regarding this co-infection. The diagnosis and treatment methods are summarized to improve clinicians' understanding of the disease and to facilitate early diagnosis and treatment. A 60-year-old male farmer with poorly controlled diabetes mellitus was admitted to hospital with a fever of unknown origin that had been present for 15 days and pulmonary aspergillosis complicated by Mucor spp. Because multiple lobes were involved, the infection worsened despite surgical resection and antifungal therapy. Finally, we treated this patient with a bronchoscopic infusion of amphotericin B. After four courses of bronchoscopic amphotericin B infusion, we observed rapid clinical improvement and subsequent resolution of pulmonary infiltrates. Our case highlights the use of bronchoscopy in the successful clinical treatment of invasive fungal diseases of the lung.</description><subject>Amphotericin B</subject><subject>Amphotericin B - administration &amp; dosage</subject><subject>Amphotericin B - therapeutic use</subject><subject>Antifungal agents</subject><subject>Antifungal Agents - administration &amp; dosage</subject><subject>Antifungal Agents - therapeutic use</subject><subject>Antiparasitic agents</subject><subject>Aspergillosis</subject><subject>Aspergillus</subject><subject>Biopsy</subject><subject>Blood vessels</subject><subject>Bronchoscopic treatment</subject><subject>Bronchoscopy</subject><subject>Care and treatment</subject><subject>Case Report</subject><subject>Case reports</subject><subject>Coinfection - drug therapy</subject><subject>Complications and side effects</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Development and progression</subject><subject>Diabetes</subject><subject>Diabetes mellitus</subject><subject>Diagnosis</subject><subject>Disease</subject><subject>Dosage and administration</subject><subject>Drug therapy</subject><subject>Drugs</subject><subject>Fatalities</subject><subject>Fungal infections</subject><subject>Health aspects</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Immunosuppressive agents</subject><subject>Infection</subject><subject>Invasive fungal infections</subject><subject>Literature reviews</subject><subject>Lung diseases</subject><subject>Lung diseases, Fungal</subject><subject>Lungs</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Middle Aged</subject><subject>Mortality</subject><subject>Mucor</subject><subject>Mucor - isolation &amp; purification</subject><subject>Mucormycosis</subject><subject>Mucormycosis - diagnosis</subject><subject>Mucormycosis - drug therapy</subject><subject>Pathogens</subject><subject>Patient outcomes</subject><subject>Patients</subject><subject>Pneumonia</subject><subject>Posaconazole</subject><subject>Pulmonary aspergillosis</subject><subject>Pulmonary Aspergillosis - diagnosis</subject><subject>Pulmonary Aspergillosis - drug therapy</subject><subject>Pulmonary mucormycosis</subject><subject>Sulbactam</subject><subject>Surgery</subject><subject>Tomography, X-Ray Computed</subject><subject>Tuberculosis</subject><issn>1471-2466</issn><issn>1471-2466</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNptkstu1DAUhiMEoqXwAiyQJTZsUnyNbTZoqLhUKmIBrC2PczLjUWIHOynQN-FtcWZKaRHywvbx9__2OT5V9ZTgU0JU8zITqjSuMeU1ZpTx-upedUy4JDXlTXP_1vqoepTzDmMilWAPqyOmKaOSyOPq1-fZOci5m3s0JbDTAGFCsUOD_wEtGud-iMGmn2iVR0gb3_dzRja06OPsYkI-dOAmHwOasw-bsp-SXacY3NbbHtlh3MYJknc-oDcLXbAYXiGLnM2AEowxTXu_3hfOTnNaopcevj-uHnS2z_Dkej6pvr57--XsQ33x6f352eqidpyLqQbHmZaWYFtyEsRppwEEE53u1gwYlpIKoZTSLdXccS0EASuoUK3oWIMFO6nOD75ttDszJj-UdE203uwDMW2MTZN3PZgOK0vsGjSXnLdropkmoCRpnQUpGlq8Xh-8xnk9QOtgKUd_x_TuSfBbs4mXhhAmGcG6OLy4dkjx2wx5MoPPDvreBohzNgXCmjSUyII-_wfdxTmFUquForx8tSB_qY0tGZQfiOVit5ialcKKUaI5LtTpf6gyWhi8iwE6X-J3BPQgcCnmnKC7SZJgs3SnOXSnKQ8x--40V0X07HZ5biR_2pH9BuOb4bc</recordid><startdate>20240904</startdate><enddate>20240904</enddate><creator>Ling, Fei-Xiang</creator><creator>Qu, Dong-Ming</creator><creator>Lu, Ye-Quan</creator><creator>Li, Rou</creator><creator>Zhao, Lei</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><general>BMC</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TO</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>COVID</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20240904</creationdate><title>Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review</title><author>Ling, Fei-Xiang ; Qu, Dong-Ming ; Lu, Ye-Quan ; Li, Rou ; Zhao, Lei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c445t-ec4397a10a92351c9c9ee535f9fb3e30772558889d294c49551ea5258d5f36053</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Amphotericin B</topic><topic>Amphotericin B - administration &amp; dosage</topic><topic>Amphotericin B - therapeutic use</topic><topic>Antifungal agents</topic><topic>Antifungal Agents - administration &amp; dosage</topic><topic>Antifungal Agents - therapeutic use</topic><topic>Antiparasitic agents</topic><topic>Aspergillosis</topic><topic>Aspergillus</topic><topic>Biopsy</topic><topic>Blood vessels</topic><topic>Bronchoscopic treatment</topic><topic>Bronchoscopy</topic><topic>Care and treatment</topic><topic>Case Report</topic><topic>Case reports</topic><topic>Coinfection - drug therapy</topic><topic>Complications and side effects</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Development and progression</topic><topic>Diabetes</topic><topic>Diabetes mellitus</topic><topic>Diagnosis</topic><topic>Disease</topic><topic>Dosage and administration</topic><topic>Drug therapy</topic><topic>Drugs</topic><topic>Fatalities</topic><topic>Fungal infections</topic><topic>Health aspects</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Immunosuppressive agents</topic><topic>Infection</topic><topic>Invasive fungal infections</topic><topic>Literature reviews</topic><topic>Lung diseases</topic><topic>Lung diseases, Fungal</topic><topic>Lungs</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Middle Aged</topic><topic>Mortality</topic><topic>Mucor</topic><topic>Mucor - isolation &amp; purification</topic><topic>Mucormycosis</topic><topic>Mucormycosis - diagnosis</topic><topic>Mucormycosis - drug therapy</topic><topic>Pathogens</topic><topic>Patient outcomes</topic><topic>Patients</topic><topic>Pneumonia</topic><topic>Posaconazole</topic><topic>Pulmonary aspergillosis</topic><topic>Pulmonary Aspergillosis - diagnosis</topic><topic>Pulmonary Aspergillosis - drug therapy</topic><topic>Pulmonary mucormycosis</topic><topic>Sulbactam</topic><topic>Surgery</topic><topic>Tomography, X-Ray Computed</topic><topic>Tuberculosis</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ling, Fei-Xiang</creatorcontrib><creatorcontrib>Qu, Dong-Ming</creatorcontrib><creatorcontrib>Lu, Ye-Quan</creatorcontrib><creatorcontrib>Li, Rou</creatorcontrib><creatorcontrib>Zhao, Lei</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Coronavirus Research Database</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>BMC pulmonary medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ling, Fei-Xiang</au><au>Qu, Dong-Ming</au><au>Lu, Ye-Quan</au><au>Li, Rou</au><au>Zhao, Lei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review</atitle><jtitle>BMC pulmonary medicine</jtitle><addtitle>BMC Pulm Med</addtitle><date>2024-09-04</date><risdate>2024</risdate><volume>24</volume><issue>1</issue><spage>436</spage><epage>6</epage><pages>436-6</pages><artnum>436</artnum><issn>1471-2466</issn><eissn>1471-2466</eissn><abstract>Reports of pulmonary aspergillosis and mucormycosis co-infections are rare; thus, limited guidance is available on early diagnosis and treatment. We present a case of mixed pulmonary Aspergillus and Mucor infection and review the literature regarding this co-infection. The diagnosis and treatment methods are summarized to improve clinicians' understanding of the disease and to facilitate early diagnosis and treatment. A 60-year-old male farmer with poorly controlled diabetes mellitus was admitted to hospital with a fever of unknown origin that had been present for 15 days and pulmonary aspergillosis complicated by Mucor spp. Because multiple lobes were involved, the infection worsened despite surgical resection and antifungal therapy. Finally, we treated this patient with a bronchoscopic infusion of amphotericin B. After four courses of bronchoscopic amphotericin B infusion, we observed rapid clinical improvement and subsequent resolution of pulmonary infiltrates. Our case highlights the use of bronchoscopy in the successful clinical treatment of invasive fungal diseases of the lung.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>39232717</pmid><doi>10.1186/s12890-024-03234-z</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-2466
ispartof BMC pulmonary medicine, 2024-09, Vol.24 (1), p.436-6, Article 436
issn 1471-2466
1471-2466
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_f08a1abe94744db19391e871dcae7562
source Open Access: PubMed Central; Publicly Available Content Database; Coronavirus Research Database
subjects Amphotericin B
Amphotericin B - administration & dosage
Amphotericin B - therapeutic use
Antifungal agents
Antifungal Agents - administration & dosage
Antifungal Agents - therapeutic use
Antiparasitic agents
Aspergillosis
Aspergillus
Biopsy
Blood vessels
Bronchoscopic treatment
Bronchoscopy
Care and treatment
Case Report
Case reports
Coinfection - drug therapy
Complications and side effects
Coronaviruses
COVID-19
Development and progression
Diabetes
Diabetes mellitus
Diagnosis
Disease
Dosage and administration
Drug therapy
Drugs
Fatalities
Fungal infections
Health aspects
Hospitals
Humans
Immunosuppressive agents
Infection
Invasive fungal infections
Literature reviews
Lung diseases
Lung diseases, Fungal
Lungs
Male
Medical prognosis
Middle Aged
Mortality
Mucor
Mucor - isolation & purification
Mucormycosis
Mucormycosis - diagnosis
Mucormycosis - drug therapy
Pathogens
Patient outcomes
Patients
Pneumonia
Posaconazole
Pulmonary aspergillosis
Pulmonary Aspergillosis - diagnosis
Pulmonary Aspergillosis - drug therapy
Pulmonary mucormycosis
Sulbactam
Surgery
Tomography, X-Ray Computed
Tuberculosis
title Successful treatment of mixed pulmonary Aspergillus and Mucor infection using intrabronchial amphotericin B infusion: a case report and literature review
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-26T23%3A54%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Successful%20treatment%20of%20mixed%20pulmonary%20Aspergillus%20and%20Mucor%20infection%20using%20intrabronchial%20amphotericin%20B%20infusion:%20a%20case%20report%20and%20literature%20review&rft.jtitle=BMC%20pulmonary%20medicine&rft.au=Ling,%20Fei-Xiang&rft.date=2024-09-04&rft.volume=24&rft.issue=1&rft.spage=436&rft.epage=6&rft.pages=436-6&rft.artnum=436&rft.issn=1471-2466&rft.eissn=1471-2466&rft_id=info:doi/10.1186/s12890-024-03234-z&rft_dat=%3Cgale_doaj_%3EA808321940%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c445t-ec4397a10a92351c9c9ee535f9fb3e30772558889d294c49551ea5258d5f36053%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=3102485351&rft_id=info:pmid/39232717&rft_galeid=A808321940&rfr_iscdi=true